Need immediate assistance? Call 1-518-730-0559 (Us-Canada Toll Free) or Contact Us

 

Breast Reconstruction Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 – 2026

Table of Content

1. Preface
     1.1. Market Definition and Scope
     1.2. Market Segmentation
     1.3. Key Research Objectives
     1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Breast Reconstruction Market

4. Market Overview
     4.1. Introduction
     4.2. Overview
     4.3. Market Dynamics
           4.3.1. Drivers
           4.3.2. Restraints
           4.3.3. Opportunities
     4.4. Global Breast Reconstruction Market Analysis and Forecast, 2016–2026

5. Key Insights
     5.1. New Product Launch and Regulatory Approvals
     5.2. Novel Technology in Breast Reconstruction

6. Global Breast Reconstruction Market Analysis and Forecast, by Product
     6.1. Introduction & Definition
     6.2. Key Findings / Developments
     6.3. Market Value Forecast, by Product, 2016–2026
           6.3.1. Breast Implants 
                    6.3.1.1. Silicone
                    6.3.1.2. Saline 
           6.3.2. Tissue Expanders
           6.3.3. Acellular Dermal Matrix (ADM)
     6.4. Market Attractiveness, by Product

7. Global Breast Reconstruction Market Analysis and Forecast, by End-user 
     7.1. Introduction & Definition
     7.2. Key Findings / Developments
     7.3. Market Value Forecast, by End-user, 2016–2026
           7.3.1. Hospitals
           7.3.2. Ambulatory Care Centers
     7.4. Market Attractiveness, by End-user 

8. Global Breast Reconstruction Market Analysis and Forecast, by Region
     8.1. Key Findings
     8.2. Market Value Forecast, by Region
           8.2.1. North America 
           8.2.2. Europe 
           8.2.3. Asia Pacific 
           8.2.4. Latin America 
           8.2.5. Middle East & Africa 
     8.3. Market Attractiveness, by Country/Region

9. North America Breast Reconstruction Market Analysis and Forecast
     9.1. Introduction
           9.1.1. Key Findings
     9.2. Market Value Forecast, by Product, 2016–2026
           9.2.1. Breast Implants 
                    9.2.1.1. Silicone
                    9.2.1.2. Saline 
           9.2.2. Tissue Expanders
           9.2.3. Acellular Dermal Matrix (ADM)
     9.3. Market Value Forecast, by End-user, 2016–2026
           9.3.1. Hospitals
           9.3.2. Ambulatory Care Centers
     9.4. Market Value Forecast, by Country, 2016–2026
           9.4.1. U.S.
           9.4.2. Canada
     9.5. Market Attractiveness Analysis 
           9.5.1. By Product
           9.5.2. By End-user 
           9.5.3. By Country

10. Europe Breast Reconstruction Market Analysis and Forecast
     10.1. Introduction
           10.1.1. Key Findings
     10.2. Market Value Forecast, by Product , 2016–2026
           10.2.1. Breast Implants 
                    10.2.1.1. Silicone
                    10.2.1.2. Saline 
           10.2.2. Tissue Expanders
           10.2.3. Acellular Dermal Matrix (ADM)
     10.3. Market Value Forecast, by End-user, 2016–2026
           10.3.1. Hospitals
           10.3.2. Ambulatory Care Centers
     10.4. Market Value Forecast, by Country/Sub-region, 2016–2026
           10.4.1. Germany
           10.4.2. U.K.
           10.4.3. France
           10.4.4. Spain
           10.4.5. Italy
           10.4.6. Rest of Europe
     10.5. Market Attractiveness Analysis 
           10.5.1. By Product
           10.5.2. By End-user 
           10.5.3. By Country/Sub-region

11. Asia Pacific Breast Reconstruction Market Analysis and Forecast
     11.1. Introduction
           11.1.1. Key Findings
     11.2. Market Value Forecast, by Product, 2016–2026
           11.2.1. Breast Implants 
                    11.2.1.1. Silicone
                    11.2.1.2. Saline 
           11.2.2. Tissue Expanders
           11.2.3. Acellular Dermal Matrix (ADM)
     11.3. Market Value Forecast, by End-user, 2016–2026
           11.3.1. Hospitals
           11.3.2. Ambulatory Care Centers
     11.4. Market Value Forecast, by Country/Sub-region, 2016–2026
           11.4.1. China
           11.4.2. Japan
           11.4.3. India
           11.4.4. Australia & New Zealand
           11.4.5. Rest of Asia Pacific
     11.5. Market Attractiveness Analysis 
           11.5.1. By Product 
           11.5.2. By End-user 
           11.5.3. By Country/Sub-region

12. Latin America Breast Reconstruction Market Analysis and Forecast
     12.1. Introduction
           12.1.1. Key Findings
     12.2. Market Value Forecast, by Product, 2016–2026
           12.2.1. Breast Implants 
                    12.2.1.1. Silicone
                    12.2.1.2. Saline 
           12.2.2. Tissue Expanders
           12.2.3. Acellular Dermal Matrix (ADM)
     12.3. Market Value Forecast, by End-user, 2016–2026
           12.3.1. Hospitals
           12.3.2. Ambulatory Care Centers
     12.4. Market Value Forecast, by Country/Sub-region, 2016–2026
           12.4.1. Brazil
           12.4.2. Mexico
           12.4.3. Rest of Latin America
     12.5. Market Attractiveness Analysis 
           12.5.1. By Product 
           12.5.2. By End-user 
           12.5.3. By Country/Sub-region

13. Middle East & Africa Breast Reconstruction Market Analysis and Forecast
     13.1. Introduction
           13.1.1. Key Findings
     13.2. Market Value Forecast, by Product, 2016–2026
           13.2.1. Breast Implants 
                    13.2.1.1. Silicone
                    13.2.1.2. Saline 
           13.2.2. Tissue Expanders
           13.2.3. Acellular Dermal Matrix (ADM)
     13.3. Market Value Forecast, by End-user, 2016–2026
           13.3.1. Hospitals
           13.3.2. Ambulatory Care Centers
     13.4. Market Value Forecast, by Country/Sub-region, 2016–2026
           13.4.1. GCC Countries
           13.4.2. South Africa
           13.4.3. Rest of Middle East & Africa
     13.5. Market Attractiveness Analysis 
           13.5.1. By Product 
           13.5.2. By End-user 
           13.5.3. By Country/Sub-region

14. Competition Landscape
     14.1. Market Share Analysis, by Company (2017)
     14.2. Company Profiles
           14.2.1. Allergan
                    14.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
                    14.2.1.2. Financial Overview
                    14.2.1.3. Product Portfolio
                    14.2.1.4. SWOT Analysis
                    14.2.1.5. Strategic Overview
           14.2.2. Mentor Worldwide LLC (Johnson & Johnson)
                    14.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
                    14.2.2.2. Financial Overview
                    14.2.2.3. Product Portfolio
                    14.2.2.4. SWOT Analysis
                    14.2.2.5. Strategic Overview
           14.2.3. Sientra, Inc.
                    14.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
                    14.2.3.2. Financial Overview
                    14.2.3.3. Product Portfolio
                    14.2.3.4. SWOT Analysis
                    14.2.3.5. Strategic Overview
           14.2.4. Establishment Labs S.A.
                    14.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
                    14.2.4.2. Financial Overview
                    14.2.4.3. Product Portfolio
                    14.2.4.4. SWOT Analysis
                    14.2.4.5. Strategic Overview
           14.2.5. POLYTECH Health & Aesthetics GmbH
                    14.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
                    14.2.5.2. Financial Overview
                    14.2.5.3. Product Portfolio
                    14.2.5.4. SWOT Analysis
                    14.2.5.5. Strategic Overview
           14.2.6. RTI Surgical, Inc.
                    14.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
                    14.2.6.2. Financial Overview
                    14.2.6.3. Product Portfolio
                    14.2.6.4. SWOT Analysis
                    14.2.6.5. Strategic Overview
           14.2.7. Groupe Sebbin SAS
                    14.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
                    14.2.7.2. Financial Overview
                    14.2.7.3. Product Portfolio
                    14.2.7.4. SWOT Analysis
                    14.2.7.5. Strategic Overview
           14.2.8. Integra LifeSciences
                    14.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
                    14.2.8.2. Financial Overview
                    14.2.8.3. Product Portfolio
                    14.2.8.4. SWOT Analysis
                    14.2.8.5. Strategic Overview
           14.2.9. Wanhe
                    14.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
                    14.2.9.2. Financial Overview
                    14.2.9.3. Product Portfolio
                    14.2.9.4. SWOT Analysis
                    14.2.9.5. Strategic Overview
           14.2.10. GC Aesthetics
                    14.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
                    14.2.10.2. Financial Overview
                    14.2.10.3. Product Portfolio
                    14.2.10.4. SWOT Analysis
                    14.2.10.5. Strategic Overview

Custom Market Research Services

MRRSE offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Get A Free Custom Research Quote